01 January 2003
Peracetic acid-ethanol treatment of allogeneic avital bone tissue transplants--areliable sterilization method.
Axel Pruss, Ulf B Gobel, Georg Pauli, Moujahed Kao, Michael Seibold, Hans Joachim Monig, Arne Hansen, Rüdiger von VersenAnn Transplant 2003; 8(2): 34-42 :: ID: 142805
Abstract
OBJECTIVES: Based on the European Standard EN 1040, the validation guidelinesof the German Federal Institute for Drugs and Medical Devices and CPMP guidelines we tested the antimicrobialeffectiveness of a peracetic acid-ethanol sterilization procedure (PES) in allogenic avital bone transplants.STUDY DESIGN: Delipidated human bone spongiosa cubes (15 x 15 x 15 mm) served as tissue. Three envelopedviruses (human immunodeficiency virus type 2, pseudorabies virus, bovine virus diarrhoea virus) and threenon-enveloped viruses (hepatitis A virus, poliovirus, porcine parvovirus) were used. The reduction ofvirus infectivity was measured as TCID50/ml in neutralized supernatants and bone homogenates. Staphylococcusaureus. Enterococcus faecium, Pseudomonas aeruginosa. Bacillus subtilis. Clostridium sporogenes, Mycobacteriumterrae. Candida albicans, Aspergillus niger as well as spores of Bacillus subtilis were tested additionally.PES led to a reduction of virus titres by more than 4 log10. Only HAV showed a reduction below 4 log10(2.87) with residual infectivity. After including a delipidating step for HAV-infected cells, a reductionof over 7 log10 HAV titre was found. For viable bacteria, fungi and spores a titre reduction below thedetection level (5 log10) was achieved after an incubation time of 2 hours. CONCLUSIONS: The peraceticacid-ethanol procedure proved to be a reliable method for the sterilization of human bone transplants(layer thickness < or = 15 mm). However, additional safety measures (anamnestic informations, infectiousserology, HIV-/HBV-/HCV-PCR in case of multiorgan donors) should be taken.
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






